logo-loader
viewEden Research PLC

Eden Research receives more country authorisations for key products

Cedroz has got full approval in the Netherlands and approval for emergency use in Italy

Eden Research PLC -
Mevalone has also had its product reach extended in Greece

Eden Research PLC (LON:EDEN), the sustainable biopesticides specialist, has reported further approvals for its Cedroz bionematicide distributed by partner Eastman Chemicals.

Italy has granted Cedroz a second 120-day emergency-use authorisation period ahead of its growing season, while full approval has been granted in the Netherlands.

Cedroz tackles root-knot nematodes, a pest that causes severe damage to crops globally, both in an open field and greenhouse situations. Cedroz’s appeal is that it is residue-free and can be applied right up to harvest.

Full authorisation for Cedroz in Italy continues to be assessed by the relevant authorities, Eden added.

The approval in the Netherlands is the third full authorisation in the European Union alongside Malta and Belgium later the same year though Eden says, unlike Italy, this is not expected to be a key market initially.

Separately, Eden said it has been notified the use of another if its products Mevalone has had approval in Greece expanded to include several minor diseases on olives and tomatoes.

In a statement, Sean Smith, Eden’s chief executive, said: "Following on from the glasshouse approval in Belgium, this approval in the Netherlands is a welcome addition to the growing portfolio of authorisations of Cedroz."

“The importance of, and growing demand for, biopesticide products in Europe is further confirmed by Italy granting emergency use authorisation for the second consecutive year Regulators recognise that biopesticides are a critical part of an integrated pest management strategy and are reacting accordingly.

“We anticipate more positive news for Cedroz in 2020 and beyond as a number of additional countries continue to review applications for full authorisation,” he added.

Quick facts: Eden Research PLC

Price: 7.81 GBX

AIM:EDEN
Market: AIM
Market Cap: £29.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research PLC named herein, including the promotion by the Company of Eden Research PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Eden Research CEO hails new office and lab space for in-house research and...

Eden Research PLC's (LON:EDEN) Sean Smith speaks to Proactive London following the announcement they've moved office and opened up a new laboratory facility at Milton Park, a science cluster in Oxfordshire. Smith says the new facility will allow them to do more in-house, including formulation,...

4 days, 21 hours ago

2 min read